Analyst Research: Cubist Pharmaceuticals Inc (CBST.O)


CBST.O on Nasdaq

51.13USD
18 Jun 2013
Price Change (% chg)

$1.16 (+2.32%)
Prev Close
$49.97
Open
$50.02
Day's High
$51.13
Day's Low
$49.82
Volume
762,394
Avg. Vol
852,400
52-wk High
$56.68
52-wk Low
$36.73

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Cubist Pharmaceuticals, Inc. 10:10am EDT Datamonitor 64 175.00
Thomson Reuters Stock Report - CUBIST PHARMACEUTICALS INCORPORATED (CBST-O) 6:06am EDT Thomson Reuters Stock Report 12 25.00
Market Edge Equity Research Report 16 Jun 2013 Market Edge 4 10.00
Cubist Pharmaceuticals 15 Jun 2013 S&P Capital IQ Factual Report 11 127.00
CUBIST PHARMACEUTICALS INC (CBST) 12-months forecast 14 Jun 2013 Pechala's Reports 1 15.00
Cubist Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 14 Jun 2013 Reuters Investment Profile 12 20.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CUBIST PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 13 Jun 2013 Jefferson Research 11 20.00
TheStreet.com Ratings Stock Report For: CUBIST PHARMACEUTICALS INC (CBST) 8 Jun 2013 TheStreet.com Ratings 5 10.00
CBST.OQ - Event Transcript of Cubist Pharmaceuticals Inc conference call, Jun. 03, 2013 / 9:00AM ET 3 Jun 2013 Thomson Reuters StreetEvents 6 75.00
 

People

Name Age Since Current Position

Kenneth Bate

 62 2011 Non-Executive Independent Chairman of the Board

Robert Perez

 48 2012 President, Chief Operating Officer

Michael Bonney

 54 2012 Chief Executive Officer, Director

Michael Tomsicek

 47 2013 Chief Financial Officer, Senior Vice President

Steven Gilman

 60 2010 Executive Vice President - Research and Development, Chief Scientific Officer
» More People

Cubist Pharmaceuticals Inc News

» More CBST.O News
Search Stocks